"Recently, injectable forms of GLP-1 RA medications such as semaglutide have been more commonly prescribed, in part related to their ability to demonstrate clinically significant weight reduction." More From Newsweek Vault: Compare the Top Health Savings Account (HSA) Providers He said that demand had "skyrocketed" as a result, but that patients "may be unaware of how several key factors including their persistence with the medication and type 2 diabetes as treatment indication, among others, might impact the long-term weight loss." "Patients have high expectations to achieve substantial weight reductions with these medications," he continued
If youre thinking about adjusting your medication regimen, be sure to consult with Dr
Although our study lacked the stringent and closely controlled nature of randomized controlled trials, we report similar weight-loss results within the same time period as in randomized controlled trials, the researchers wrote
This date determines everything that follows
Only one episode of severe hypoglycaemia was reported in the patients treated with Wegovy
